Autism Spectrum Disordere-GOLIAH-ECONCT05271955
e-GOLIAH in Autistic Spectrum Disorders
A study testing "e-GOLIAH" in people with Autism Spectrum Disorder, run by Assistance Publique - Hôpitaux de Paris at 12 sites in France.
Trial summary
Randomized open-label study comparing children aged 3 to 6 years with autism and normal cognitive development or mild cognitive impairment receiving the usual treatment plus intensive use of eGOLIAH (experimental group) with children receiving only the usual treatment (control group). Read more about this study
- Who is it for?
- Ages 3 to 6 years
- Conditions the study is for
- Autism Spectrum Disorder
- What is being tested?
- "e-GOLIAH"
- Type of treatment
- Pill or oral medicine, Medical device, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 150 participants
- Where
- 12 sitesFrance
- Study dates
- 15 Jun 2022to 15 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 6 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Child with autism confirmed by a validated instrument (ADI-R or ADOS)
- Aged 3 to 6 years;
- Parent(s) agree to get involved in the constraint of using the SG 5 times / week at home for 2 periods of 3 months.
- Signature of the informed consent form by the 2 holders of parental authority or the only holder of parental authority present
- Affiliation to a social security scheme (except AME)
- Non-inclusion criteria :
Show all 13Show fewer
- Children with behavioral problems;
- Unstabilized comorbid organic pathology;
- Moderate and severe cognitive deficit (Intellectual Quotient less than 55);
- Multi or polyhandicap.
- Medication that may cause visual or cognitive impairment (PSAs, neuroleptics, etc.) or that may interfere with the study assessments
- Degenerative diseases or any other disease that could interfere with the evaluations planned during this study (known epilepsy and/or history of seizures, etc.)
- Photosensitive persons in order to avoid situations that could induce epileptic seizures in them
Who cannot join
None listed.
Trial locations and contacts
12 sites in 1 country.
12 sites in 1 country
France12 sites
Centre Hospitalier d'Amiens
Amiens, Somme, 80054
Doctor Xavier BENAROUS, Child Psychiatrist, +33(0)3.22.82.53.63, benarous.xavier@chu-amiens.fr
Doctor Xavier BENAROUS, Child Psychiatrist
Centre Hospitalier Universitaire de Montpellier
Montpellier, Hérault, 34295
Professor Amaria BAGHDADLI, Child Psychiatrist, +33(0)4.67.33.96.96, a-baghdadli@chu-montpellier.fr
Professor Amaria BAGHDADLI, Child Psychiatrist
Centre Hospitalier Universitaire de Nancy
Nancy, Meurthe-et-Moselle, 54511
Professor Bernard KABUTH, Child Psychiatrist, +33(0)3.83.15.45.53, bernard.kabuth@cpn-laxou.com
Professor Bernard KABUTH, Child Psychiatrist
Fondation Lenval - Hôpitaux Pédiatriques de Nice- CHU Lenval
Nice, Alpes Maritimes, 06200
Doctor Suzanne THÜMMLER, Child Psychiatrist, +33(0)4.92.03.04.39, thummler.s@pediatrie-chulenval-nice.fr
Doctor Suzanne THÜMMLER, Child Psychiatrist
Assistance Publique - Hôpitaux de Paris, Site de la Pitié-Salpêtrière
Paris, Île-de-France Region, 75013
Pr David COHEN, Child Psychiatrist, +33(0)1.42.16.23.51, david.cohen@aphp.fr
Isabelle MOREAU-BABILAERE, Secretary, +33(0)1.42.16.23.51, isabelle.babilaere@aphp.fr
Centre Hospitalier Sainte-Anne / GHU Paris Psychiatrie et Neurosciences
Paris, Île-de-France Region, 75014
Doctor Catherine DOYEN, Child Psychiatrist, +33(0)1.45.65.81.24, c.doyen@ch-sainte-anne.fr
Doctor Catherine DOYEN, Child Psychiatrist
Assistance Publique - Hôpitaux de Paris, Site de Necker
Paris, Île-de-France Region, 75015
Professor Pauline CHASTE, Child Psychiatrist, +33(0)1.44.49.45.61, pauline.chaste@aphp.fr
Professor Pauline CHASTE, Child Psychiatrist
Centre Hospitalier Universitaire de Paris - Centre Hospitalier d'Henri Laborit
Poitiers, Vienne, 86021
Professor Jean XAVIER, Child Psychiatrist, +33(0)5.49.44.57.57, jean.xavier@ch-poitiers.fr
Professor Jean XAVIER, Child Psychiatrist
Centre Hospitalier Universitaire de Strasbourg
Strasbourg, Bas-Rhin, 67091
Professor Carmen SCHRÖDER, Child Psychiatrist, +33(0)3.88.11.62.18, schroderc@unistra.fr
Professor Carmen SCHRÖDER, Child Psychiatrist
Centre Hospitalier Universitaire de Toulouse
Toulouse, Haut-Garonne, 31059
Professor Jean-Philippe RAYNAUD, Child Psychiatrist, +33(0)5.61.77.60.55, raynaud.jp@chu-toulouse.fr
Professor Jean-Philippe RAYNAUD, Child Psychiatrist
Centre Hospitalier Universitaire de Tours
Tours, Indre-et-Loire, 37044
Professor Frédérique BONNET-BRILHAULT, Child Psychiatrist, +33(0)2.47.47.84.12, frederique.brilhault@univ-tours.fr
Professor Frédérique BONNET-BRILHAULT, Child Psychiatrist
Centre Hospitalier de Versailles - André Mignot
Versailles, Île-de-France Region, 78157
Professor Mario SPERANZA, Child Psychiatrist, +33(0)1.39.63.85.43, msperanza@ch-versailles.fr
Professor Mario SPERANZA, Child Psychiatrist
About this study
Official title: Medico-economic Evaluation of the Care by Serious Games in Outpatient Units and at Home for Children With Autism Spectrum Disorders
Randomized open-label study comparing children aged 3 to 6 years with autism and normal cognitive development or mild cognitive impairment receiving the usual treatment plus intensive use of eGOLIAH (experimental group) with children receiving only the usual treatment (control group).
eGOLIAH (Gaming Open Library for Intervention in Autism at Home) is an accessible online platform for digital games inspired by the principles of the Early Start Denver Model (ESDM), one of the care programs validated in the management of young ASD.
Read more
The duration per patient will be one year. The exposure to e-GOLIAH for the experimental group will be done with the recommendation of intensive exposure to the game (5 sessions> ½ hour per week).
Clinical variables will be assessed at entry, 6 months and 1 year (end of study).
The EQ5D questionnaires will be collected by the supervising therapist during the follow-up visit and at the same time as the clinical variables.
Read the detailed description
In a context of increasing prevalence of Autism Spectrum Disorder (ASD) and the heterogeneity of children's profiles and abilities, early diagnosis is crucial in order to implement intensive, individualized, multidimensional therapeutic care and therefore more efficient. In the context of MICHELANGELO (FP7 European Research project), we developed a serious game called GOLIAH for Gaming Open Library for Intervention for Autism at Home. Using the first beta version as functional prototype, we showed that the demonstrator could be used at home with the help of parents in addition to usual care, during a clinical study including 25 participants. Also, Billeci and colleagues showed that, after training, children's improvement in joint attention tasks was correlated with changes in brain activity and connectivity. We then developed a new version e-GOLIAH to open the opportunity to conduct a large clinical study to assess the validity of the tool in terms of children's improvements. The goals of e-GOLIAH are to bring improvements in terms of ergonomics and accessibility to this initial prototype by finalizing the tool and distributing it to therapists, parents and children with ASD, via the Curapy.com web platform. e-GOLIAH provides, in free and open access, a platform for digital games inspired by the principles of ESDM (Early Start Denver Model) allowing intensive training to improve joint attention and imitation, two key skills for early social interaction and communication. It is a more natural, child-centered intervention method practiced at home and involving parents. This innovative solution takes the assessment and management of autism care out of the usual clinical environment. eGOLIAH (Gaming Open Library for Intervention in Autism at Home) is an accessible online platform for digital games that include ten different games with different level of complexity. A key principle is the collaboration between the child and his/her parent to proceed with the games making it interactive by nature, each participant having his own tablet.
The current study e-GOLIAH-ECO is a medico-economic study powered to recruit 150 children. It is a multisite randomized open-label study comparing children aged 3 to 6 years with autism and normal cognitive development or mild cognitive impairment receiving the usual treatment plus intensive use of eGOLIAH (experimental group) with children receiving only the usual treatment (control group).
The duration per patient will be one year. The exposure to e-GOLIAH for the experimental group will be done with the recommendation of intensive exposure to the game (5 sessions> ½ hour per week).
Clinical variables will be assessed at entry, 6 months and 1 year (end of study). The EQ5D (quality of life) questionnaires will be collected by the supervising therapist during the follow-up visit and at the same time as the clinical variables.
The main objective is to evaluate the 12-month cost-effectiveness of the management of children diagnosed with ASDs using the e-GOLIAH game used at home, compared to usual management.
Secondary objective includes:
(i) To evaluate the cost-effectiveness ratio of the management of patients with ASDs using e-GOLIAH compared to usual management at 12 months of follow-up.
(ii) To explore the remaining ASD-related annual burden of the cost of disease for the two groups studied.
(iii) To evaluate the consequences of the generalization of the management of children diagnosed with ASD using e-GOLIAH, compared to a usual management, from the point of view of the Health Insurance over a period of 3 years.
(iv) To evaluate the impact of the management of children diagnosed with ASD using the e-GOLIAH game used at home, compared to usual management, on the patient's quality of life and that of their responsible parent and the correlation between the two, on adaptive symptoms, on autistic symptoms, on social interactions, on parental stress, at 6 months and at 12 months.
(v) To assess compliance with OS by children and their caregivers. The following scales will be monitored: the EQ5D-3L for quality of life, the Vineland-II scale, the Child Autism Rating Scale (CARS), the Social Responsiveness Scale (SRS), the Parenting Stress Index. In addition the medico-economic data will be monitored from regular interview and social insurance data.
- Conditions
- Autism Spectrum Disorder
- Being tested
- "e-GOLIAH", Usual care
- Keywords
- e-GOLIAH, e-GOLIAH-ECO, Autistic Spectrum Disorders, Children, Tablet, Games, Serious Game
- Medical subject headings
- Autism Spectrum Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
"e-GOLIAH"Device
Usual care plus electronic tablet with games application "e-GOLIAH" (Gaming Open Library for Intervention in Autism at Home)
Usual careBehavioural
Usual care which combines speech therapy, psychomotor, educational or psychological care with a developmental and / or behavioral orientation and a school life support during schooling.
| Study group | Role | What they receive |
|---|---|---|
| Experimental | Experimental | Children receiving the usual care plus intensive use of e-GOLIAH (experimental group) Receives: Device: "e-GOLIAH" |
| Control | Active comparator | Children receiving only the usual treatment (control group). Receives: Behavioral: Usual care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Comparison of Incremental Cost-Utility Ratio (ICUR) at 12 months between the 2 groups
ICUR use the 5-level EQ-5D version and the child-friendly EQ-5D version (EQ5D-5L/EQ5D-Y) questionnaires (min score : 0 ; max score : 100 ; higher scores mean a better outcome)
Measured: 12 months
Secondary outcomes (10)
Comparison of Incremental Cost-utility ratio (ICUR) at 6 months between the 2 groups
ICUR use the 5-level EQ-5D version and the child-friendly EQ-5D version (EQ5D-5L/EQ5D-Y) questionnaires (min score : 0 ; max score : 100 ; higher scores mean a better outcome)
Measured: 6 months
Comparison of Incremental cost-effectiveness ratio (ICER) between the 2 groups
ICER use the Vineland II scale (undetermined minimum and maximum)composite score, average score : 100, higher scores mean a better outcome)
Measured: 6 and 12 months
Comparison of the out of pocket payment for the consumption of treatments linked to the TSA between the 2 groups
Amount remaining payable by the patient after deduction of reimbursements received by health insurance
Measured: 12 months
Budget impact analysis (BIA) of e-GOLIAH in the management of children diagnosed with TSA for health insurance
Budget impact analysis (BIA) will be measured by direct resources consumed and quantified using the SNIIRAM/SNDS database
Measured: 3 years
Comparison of Quality of life between the 2 groups
Measured by the 5-level EQ-5D version and the child-friendly EQ-5D version measured by proxy EQ-5D-5L/EQ-5D-Y(proxy) for the patient and their parent. Scale 0-100 (min score: 0, max score :100, higher scores mean a better outcome)
Measured: 6 and 12 months
Comparison of Adaptive symptoms between the 2 groups
Use the Vineland-II Scale of socio-adaptive behavior measured by the composite score with an average to 100 of 4 dimensions: socialization, communication, life skills everyday life, and motricity (undetermined minimum and maximum composite score, average score : 100, higher scores mean a better outcome)
Measured: 6 and 12 months
Comparison of Autistic symptoms between the 2 groups
Use the CARS (Child Autism Rating Ladder) scale, 15 items coded from 1 to 4 (score min: 0, max : 60, higher scores mean a worse outcome)
Measured: 6 and 12 months
Comparison of Social interactions between the 2 groups
Use the SRS (Social Responsiveness Scale) scale, 65 items coded from 1 to 4 (score min: 0 ; score max : 260, higher scores mean a worse outcome)
Measured: 6 and 12 months
Comparison of Parental Stress between the 2 groups
Use the Parental Stress Index scale, 36 items coded from 1 to 5 (score min : 0 ; max: 180, higher scores mean a worse outcome)
Measured: 6 and 12 months
The child's acceptability to the e-GOLIAH game at home
interview with clinical team by phone contact every twice a month for 12 months
Measured: 6 and 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Mar 2022
- Study start15 Jun 2022 (estimated)
- Primary completion15 Dec 2024 (estimated)
- Study completion15 Dec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Autism Spectrum DisorderStudies of the same condition, open and under way.
- More trials run by Assistance Publique - Hôpitaux de ParisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 150 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Collaborators
- University Hospital, Montpellier
- Responsible party
- Sponsor
- Investigators
- David COHEN, Professor, Study director, Assistance Publique - Hôpitaux de Paris
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05271955
- Sponsor's protocol ID
- APHP200052
- Other IDs
- 2020-A03389-30
- Acronym
- e-GOLIAH-ECO
- Status last verified
- Feb 2022
- First submitted
- 28 Feb 2022
- Last updated
- 25 Apr 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, Donaldson A, Varley J. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics. 2010 Jan;125(1):e17-23. doi: 10.1542/peds.2009-0958. Epub 2009 Nov 30.
PubMed 19948568Jouen AL, Narzisi A, Xavier J, Tilmont E, Bodeau N, Bono V, Ketem-Premel N, Anzalone S, Maharatna K, Chetouani M, Muratori F, Cohen D; MICHELANGELO Study Group. GOLIAH (Gaming Open Library for Intervention in Autism at Home): a 6-month single blind matched controlled exploratory study. Child Adolesc Psychiatry Ment Health. 2017 Mar 22;11:17. doi: 10.1186/s13034-017-0154-7. eCollection 2017.
PubMed 28344643Bieleninik L, Geretsegger M, Mossler K, Assmus J, Thompson G, Gattino G, Elefant C, Gottfried T, Igliozzi R, Muratori F, Suvini F, Kim J, Crawford MJ, Odell-Miller H, Oldfield A, Casey O, Finnemann J, Carpente J, Park AL, Grossi E, Gold C; TIME-A Study Team. Effects of Improvisational Music Therapy vs Enhanced Standard Care on Symptom Severity Among Children With Autism Spectrum Disorder: The TIME-A Randomized Clinical Trial. JAMA. 2017 Aug 8;318(6):525-535. doi: 10.1001/jama.2017.9478.
PubMed 28787504Billeci L, Narzisi A, Tonacci A, Sbriscia-Fioretti B, Serasini L, Fulceri F, Apicella F, Sicca F, Calderoni S, Muratori F. An integrated EEG and eye-tracking approach for the study of responding and initiating joint attention in Autism Spectrum Disorders. Sci Rep. 2017 Oct 19;7(1):13560. doi: 10.1038/s41598-017-13053-4.
PubMed 29051506Bono V, Narzisi A, Jouen AL, Tilmont E, Hommel S, Jamal W, Xavier J, Billeci L, Maharatna K, Wald M, Chetouani M, Cohen D, Muratori F; MICHELANGELO Study Group. GOLIAH: A Gaming Platform for Home-Based Intervention in Autism - Principles and Design. Front Psychiatry. 2016 Apr 28;7:70. doi: 10.3389/fpsyt.2016.00070. eCollection 2016.
PubMed 27199777
Study at a glance
From the registry record, last updated by the sponsor on 25 Apr 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Medico-economic Evaluation of the Care by Serious Games in Outpatient Units and at Home for Children With Autism Spectrum Disorders
- ClinicalTrials.gov ID
- NCT05271955
- Acronym / sponsor ID
- e-GOLIAH-ECO / APHP200052
- Conditions
- Autism Spectrum Disorder
- Keywords
- e-GOLIAH, e-GOLIAH-ECO, Autistic Spectrum Disorders, Children, Tablet, Games, Serious Game
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisUniversity, hospital or other
- Collaborators
- University Hospital, Montpellier
- Study start
- 15 Jun 2022 (estimated)
- Primary completion
- 15 Dec 2024 (estimated)
- Study completion
- 15 Dec 2024 (estimated)
- First posted
- 9 Mar 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Randomized open-label study comparing children aged 3 to 6 years with autism and normal cognitive development or mild cognitive impairment receiving the usual treatment plus intensive use of eGOLIAH (experimental group) with children receiving only the usual treatment (control group).
eGOLIAH (Gaming Open Library for Intervention in Autism at Home) is an accessible online platform for digital games inspired by the principles of the Early Start Denver Model (ESDM), one of the care programs validated in the management of young ASD.
The duration per patient will be one year. The exposure to e-GOLIAH for the experimental group will be done with the recommendation of intensive exposure to the game (5 sessions> ½ hour per week).
Clinical variables will be assessed at entry, 6 months and 1 year (end of study).
The EQ5D questionnaires will be collected by the supervising therapist during the follow-up visit and at the same time as the clinical variables.
Detailed description
In a context of increasing prevalence of Autism Spectrum Disorder (ASD) and the heterogeneity of children's profiles and abilities, early diagnosis is crucial in order to implement intensive, individualized, multidimensional therapeutic care and therefore more efficient. In the context of MICHELANGELO (FP7 European Research project), we developed a serious game called GOLIAH for Gaming Open Library for Intervention for Autism at Home. Using the first beta version as functional prototype, we showed that the demonstrator could be used at home with the help of parents in addition to usual care, during a clinical study including 25 participants. Also, Billeci and colleagues showed that, after training, children's improvement in joint attention tasks was correlated with changes in brain activity and connectivity. We then developed a new version e-GOLIAH to open the opportunity to conduct a large clinical study to assess the validity of the tool in terms of children's improvements. The goals of e-GOLIAH are to bring improvements in terms of ergonomics and accessibility to this initial prototype by finalizing the tool and distributing it to therapists, parents and children with ASD, via the Curapy.com web platform. e-GOLIAH provides, in free and open access, a platform for digital games inspired by the principles of ESDM (Early Start Denver Model) allowing intensive training to improve joint attention and imitation, two key skills for early social interaction and communication. It is a more natural, child-centered intervention method practiced at home and involving parents. This innovative solution takes the assessment and management of autism care out of the usual clinical environment. eGOLIAH (Gaming Open Library for Intervention in Autism at Home) is an accessible online platform for digital games that include ten different games with different level of complexity. A key principle is the collaboration between the child and his/her parent to proceed with the games making it interactive by nature, each participant having his own tablet.
The current study e-GOLIAH-ECO is a medico-economic study powered to recruit 150 children. It is a multisite randomized open-label study comparing children aged 3 to 6 years with autism and normal cognitive development or mild cognitive impairment receiving the usual treatment plus intensive use of eGOLIAH (experimental group) with children receiving only the usual treatment (control group).
The duration per patient will be one year. The exposure to e-GOLIAH for the experimental group will be done with the recommendation of intensive exposure to the game (5 sessions> ½ hour per week).
Clinical variables will be assessed at entry, 6 months and 1 year (end of study). The EQ5D (quality of life) questionnaires will be collected by the supervising therapist during the follow-up visit and at the same time as the clinical variables.
The main objective is to evaluate the 12-month cost-effectiveness of the management of children diagnosed with ASDs using the e-GOLIAH game used at home, compared to usual management.
Secondary objective includes:
(i) To evaluate the cost-effectiveness ratio of the management of patients with ASDs using e-GOLIAH compared to usual management at 12 months of follow-up.
(ii) To explore the remaining ASD-related annual burden of the cost of disease for the two groups studied.
(iii) To evaluate the consequences of the generalization of the management of children diagnosed with ASD using e-GOLIAH, compared to a usual management, from the point of view of the Health Insurance over a period of 3 years.
(iv) To evaluate the impact of the management of children diagnosed with ASD using the e-GOLIAH game used at home, compared to usual management, on the patient's quality of life and that of their responsible parent and the correlation between the two, on adaptive symptoms, on autistic symptoms, on social interactions, on parental stress, at 6 months and at 12 months.
(v) To assess compliance with OS by children and their caregivers. The following scales will be monitored: the EQ5D-3L for quality of life, the Vineland-II scale, the Child Autism Rating Scale (CARS), the Social Responsiveness Scale (SRS), the Parenting Stress Index. In addition the medico-economic data will be monitored from regular interview and social insurance data.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experimental | Experimental | Device: "e-GOLIAH"Children receiving the usual care plus intensive use of e-GOLIAH (experimental group) |
| Control | Active comparator | Behavioral: Usual careChildren receiving only the usual treatment (control group). |
Who may qualify
- Ages
- 3 to 6 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (13 listed)
- Child with autism confirmed by a validated instrument (ADI-R or ADOS)
- Aged 3 to 6 years;
- Parent(s) agree to get involved in the constraint of using the SG 5 times / week at home for 2 periods of 3 months.
- Signature of the informed consent form by the 2 holders of parental authority or the only holder of parental authority present
- Affiliation to a social security scheme (except AME)
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| "e-GOLIAH"Usual care plus electronic tablet with games application "e-GOLIAH" (Gaming Open Library for Intervention in Autism at Home) | Device | Experimental |
| Usual careUsual care which combines speech therapy, psychomotor, educational or psychological care with a developmental and / or behavioral orientation and a school life support during schooling. | Behavioural | Control |
Primary outcome
Comparison of Incremental Cost-Utility Ratio (ICUR) at 12 months between the 2 groups
Time frame: 12 months
ICUR use the 5-level EQ-5D version and the child-friendly EQ-5D version (EQ5D-5L/EQ5D-Y) questionnaires (min score : 0 ; max score : 100 ; higher scores mean a better outcome)
10 secondary outcomes
Comparison of Incremental Cost-utility ratio (ICUR) at 6 months between the 2 groups
Time frame: 6 months
Comparison of Incremental cost-effectiveness ratio (ICER) between the 2 groups
Time frame: 6 and 12 months
Comparison of the out of pocket payment for the consumption of treatments linked to the TSA between the 2 groups
Time frame: 12 months
Budget impact analysis (BIA) of e-GOLIAH in the management of children diagnosed with TSA for health insurance
Time frame: 3 years
Comparison of Quality of life between the 2 groups
Time frame: 6 and 12 months
Comparison of Adaptive symptoms between the 2 groups
Time frame: 6 and 12 months
Comparison of Autistic symptoms between the 2 groups
Time frame: 6 and 12 months
Comparison of Social interactions between the 2 groups
Time frame: 6 and 12 months
Comparison of Parental Stress between the 2 groups
Time frame: 6 and 12 months
The child's acceptability to the e-GOLIAH game at home
Time frame: 6 and 12 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Apr 2022.
- Background: PubMed 19948568Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, Donaldson A, Varley J. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics. 2010 Jan;125(1):e17-23. doi: 10.1542/peds.2009-0958. Epub 2009 Nov 30.
- Background: PubMed 28344643Jouen AL, Narzisi A, Xavier J, Tilmont E, Bodeau N, Bono V, Ketem-Premel N, Anzalone S, Maharatna K, Chetouani M, Muratori F, Cohen D; MICHELANGELO Study Group. GOLIAH (Gaming Open Library for Intervention in Autism at Home): a 6-month single blind matched controlled exploratory study. Child Adolesc Psychiatry Ment Health. 2017 Mar 22;11:17. doi: 10.1186/s13034-017-0154-7. eCollection 2017.
- Background: PubMed 28787504Bieleninik L, Geretsegger M, Mossler K, Assmus J, Thompson G, Gattino G, Elefant C, Gottfried T, Igliozzi R, Muratori F, Suvini F, Kim J, Crawford MJ, Odell-Miller H, Oldfield A, Casey O, Finnemann J, Carpente J, Park AL, Grossi E, Gold C; TIME-A Study Team. Effects of Improvisational Music Therapy vs Enhanced Standard Care on Symptom Severity Among Children With Autism Spectrum Disorder: The TIME-A Randomized Clinical Trial. JAMA. 2017 Aug 8;318(6):525-535. doi: 10.1001/jama.2017.9478.
- Background: PubMed 29051506Billeci L, Narzisi A, Tonacci A, Sbriscia-Fioretti B, Serasini L, Fulceri F, Apicella F, Sicca F, Calderoni S, Muratori F. An integrated EEG and eye-tracking approach for the study of responding and initiating joint attention in Autism Spectrum Disorders. Sci Rep. 2017 Oct 19;7(1):13560. doi: 10.1038/s41598-017-13053-4.
- Background: PubMed 27199777Bono V, Narzisi A, Jouen AL, Tilmont E, Hommel S, Jamal W, Xavier J, Billeci L, Maharatna K, Wald M, Chetouani M, Cohen D, Muratori F; MICHELANGELO Study Group. GOLIAH: A Gaming Platform for Home-Based Intervention in Autism - Principles and Design. Front Psychiatry. 2016 Apr 28;7:70. doi: 10.3389/fpsyt.2016.00070. eCollection 2016.
Related trials for Autism Spectrum Disorder
Recruiting
Effectiveness of Clown Therapy in Facilitating Dental Visits for Children With Autism Spectrum Disorder
Autism Spectrum Disorder (ASD
Recruiting
Cerebellar Transcranial Direct Current Stimulation (tDCS) in Children With Autism Spectrum Disorder: Raynor Cerebellum Project
Autism Spectrum Disorder
Not yet recruiting
QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)
Asperger's Disorder, Asperger Disorder
Not yet recruiting
Transdiagnostic Sleep and Circadian Treatment for Autistic Adolescents
Sleep, Autism Spectrum Disorder
RecruitingObservational study
Effectiveness of the Autism Pupil Screen (APS) Detect Pupillometer for Identifying Autism Spectrum Disorder (ASD) in Routine Healthcare
Autism Spectrum Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
David COHEN, Professor study director
Assistance Publique - Hôpitaux de Paris
12 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing "e-GOLIAH" in people with Autism Spectrum Disorder, run by Assistance Publique - Hôpitaux de Paris at 12 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 13 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 25 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 12 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact David COHEN, Professor, Child Psychiatrist (01 42 16 23 51 ext. +33, david.cohen@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Comparison of Incremental Cost-Utility Ratio (ICUR) at 12 months between the 2 groups (time frame: 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05271955, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2022.